Novo Nordisk A/S
An Associate Director will lead the Centre for Functional Assay & Screening within Novo Nordisk's Therapeutics Discovery division. The role involves managing a team of scientists and technicians to develop high-throughput biological assays for early-stage drug discovery, while fostering a collaborative leadership environment and driving cross-functional screening strategies.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
29% below the average for this role
Research Specialist / Sr Scientist, Assay Sciences, Discovery Pharmacology
Altos Labs
Scientist, Screening Biology
Orbis Medicines
Director / Senior Director, Small Molecule Therapeutics
Lila Sciences
Principal Scientist: PKDM-BA (Small molecule in vitro ADME group lead)
Amgen
Senior Scientist – Assay Development & Screening
Novartis
Scientist II, Assay Operations, Screening Platform Technologies (SPT)
Revolution Medicines